ASC Therapeutics
Steve Zhang is currently the VP of Gene and Cell Therapy at ASC Therapeutics since 2018. Before that, Steve worked at Sangamo Therapeutics, Inc. from 2000 to 2017, where Steve held the title of Associate Director, Therapeutic Gene Regulation. Steve earned a Ph.D. in Molecular Genetics from Washington University in St. Louis.
This person is not in any offices
ASC Therapeutics
ASC Therapeutics focuses on the development of curative therapies for rare diseases.